⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTMX News
CytomX Therapeutics, Inc.
CytomX Therapeutics Announces Business Update and Company Milestones for 2026
globenewswire.com
CTMX
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
globenewswire.com
VERA
GILD
SANG
CTMX
CytomX Therapeutics to Present at Upcoming December Investor Conferences
globenewswire.com
CTMX
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
globenewswire.com
CTMX
CytomX Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
CTMX
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
globenewswire.com
CTMX
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
globenewswire.com
CTMX